Publication Information

{'id': 'https://openalex.org/W2350497213', 'doi': None, 'title': 'Assessment of clinical efficacy of mesalazine suppositories on active mild or moderate ulcerative colonitis', 'display_name': 'Assessment of clinical efficacy of mesalazine suppositories on active mild or moderate ulcerative colonitis', 'publication_year': 2015, 'publication_date': '2015-01-01', 'ids': {'openalex': 'https://openalex.org/W2350497213', 'mag': '2350497213'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-LCYW201502012.htm', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030465849', 'display_name': 'Yang Shi-we', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I154099455', 'display_name': 'Shandong University', 'ror': 'https://ror.org/0207yh398', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I154099455']}, {'id': 'https://openalex.org/I4210153274', 'display_name': 'Shandong Provincial QianFoShan Hospital', 'ror': 'https://ror.org/03wnrsb51', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153274']}], 'countries': ['CN'], 'is_corresponding': True, 'raw_author_name': 'Yang Shi-we', 'raw_affiliation_strings': ['Shandong Anorectal Hospital, Qianfoshan Hospital Affiliated to Shandong University'], 'affiliations': [{'raw_affiliation_string': 'Shandong Anorectal Hospital, Qianfoshan Hospital Affiliated to Shandong University', 'institution_ids': ['https://openalex.org/I154099455', 'https://openalex.org/I4210153274']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5030465849'], 'corresponding_institution_ids': ['https://openalex.org/I154099455', 'https://openalex.org/I4210153274'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10134', 'display_name': 'Inflammatory Bowel Disease', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11316', 'display_name': 'Mycobacterium research and diagnosis', 'score': 0.9869, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12817', 'display_name': 'Pharmacological Effects of Natural Compounds', 'score': 0.9857, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/mesalazine', 'display_name': 'Mesalazine', 'score': 0.96284986}, {'id': 'https://openalex.org/keywords/sulfasalazine', 'display_name': 'Sulfasalazine', 'score': 0.75031626}, {'id': 'https://openalex.org/keywords/group-b', 'display_name': 'Group B', 'score': 0.5626121}, {'id': 'https://openalex.org/keywords/group-a', 'display_name': 'Group A', 'score': 0.41113028}], 'concepts': [{'id': 'https://openalex.org/C2779174533', 'wikidata': 'https://www.wikidata.org/wiki/Q412479', 'display_name': 'Mesalazine', 'level': 4, 'score': 0.96284986}, {'id': 'https://openalex.org/C2780479503', 'wikidata': 'https://www.wikidata.org/wiki/Q1477', 'display_name': 'Ulcerative colitis', 'level': 3, 'score': 0.8692384}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8445494}, {'id': 'https://openalex.org/C2779383735', 'wikidata': 'https://www.wikidata.org/wiki/Q420035', 'display_name': 'Sulfasalazine', 'level': 4, 'score': 0.75031626}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.66740173}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.665037}, {'id': 'https://openalex.org/C2777785397', 'wikidata': 'https://www.wikidata.org/wiki/Q492194', 'display_name': 'Group B', 'level': 2, 'score': 0.5626121}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.48447964}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.4796196}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.44576892}, {'id': 'https://openalex.org/C2780678043', 'wikidata': 'https://www.wikidata.org/wiki/Q743241', 'display_name': 'Group A', 'level': 2, 'score': 0.41113028}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-LCYW201502012.htm', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.49, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3029664240', 'https://openalex.org/W2614583537', 'https://openalex.org/W2392725485', 'https://openalex.org/W2386497540', 'https://openalex.org/W2385800859', 'https://openalex.org/W2384949279', 'https://openalex.org/W2377486882', 'https://openalex.org/W2361796690', 'https://openalex.org/W2361556633', 'https://openalex.org/W2355129079', 'https://openalex.org/W2353019440', 'https://openalex.org/W2350089982', 'https://openalex.org/W2349558415', 'https://openalex.org/W2347223478', 'https://openalex.org/W2093909822', 'https://openalex.org/W2085520559', 'https://openalex.org/W2069333891', 'https://openalex.org/W1996348098', 'https://openalex.org/W1990013125', 'https://openalex.org/W1984132076'], 'abstract_inverted_index': {'Objective:': [0], 'To': [1], 'evaluate': [2], 'the': [3, 11, 115, 171, 178], 'efficacy': [4], 'and': [5, 38, 102, 106, 124, 132, 134, 163, 168, 198], 'safety': [6], 'of': [7, 13, 34, 36, 44, 63, 99, 121, 143, 151, 157, 185], 'Mesalazine': [8, 186], 'Suppositories': [9, 187], 'on': [10, 42, 188], 'treatment': [12, 43], 'active': [14], 'mild': [15, 27, 190], 'or': [16, 28, 191], 'moderate': [17, 29, 192], 'ulcerative': [18, 45, 193], 'colitis(UC).': [19], 'Methods:': [20], '64': [21], 'patients': [22, 66], 'who': [23], 'were': [24, 49, 67, 104], 'diagnosed': [25], 'as': [26], 'UC': [30], 'based': [31], 'on(the': [32], 'Consensus': [33], 'cooperation': [35], 'Chinese': [37], 'western': [39], 'medicine': [40], 'diagnosis': [41], 'colitis': [46, 194], 'in': [47, 51], '2010)': [48], 'enrolled': [50], 'this': [52], 'randomized,': [53], 'multicenter,': [54], 'double': [55, 57], 'blind,': [56], 'dummy,': [58], 'andparallel': [59], 'controlled': [60], 'study.': [61], 'Among': [62], 'them,': [64], '32': [65, 81], 'assigned': [68], 'to': [69, 82], 'receive': [70, 84], '1.5': [71], 'g': [72, 86], 'mesalazine': [73], 'suppositories': [74], 'daily': [75, 89], 'for': [76, 90, 160], '8': [77, 91, 135], 'weeks(Group': [78, 92], 'A),': [79], 'another': [80], 'orally': [83], '3': [85], 'Sulfasalazine': [87], 'tablets': [88], 'B).': [93], 'Results:': [94], 'The': [95, 140, 155], 'total': [96], 'effective': [97], 'rates': [98], 'Group': [100, 122, 144, 152, 164], 'A': [101, 123, 145, 162], 'B': [103, 125, 165], '90.625%': [105], '71.875%,': [107], 'respectively.': [108], 'There': [109], 'was': [110, 146, 166, 195], 'significant': [111, 127, 174], 'statistical': [112, 128, 175], 'difference': [113, 176], 'between': [114, 130, 177], 'two': [116, 179], 'groups(P': [117, 180], '0.05).The': [118], 'endoscopic': [119, 141], 'index': [120, 142], 'had': [126], 'differences': [129], 'before': [131], '2,4,': [133], 'weeks': [136], 'after': [137], 'administration(P': [138], '0.05).': [139, 154, 181], 'much': [147], 'lower': [148], 'than': [149], 'that': [150], 'B(P': [153], 'incidence': [156], 'adverse': [158], 'reaction': [159], 'group': [161], '3.125%': [167], '31.25%': [169], 'during': [170], 'treatment,': [172], 'with': [173], 'Conclusion:Clinical': [182], 'curative': [183], 'effect': [184], 'treating': [189], 'more': [196], 'remarkable': [197], 'safe.': [199]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2350497213', 'counts_by_year': [], 'updated_date': '2024-12-15T14:09:28.752024', 'created_date': '2016-06-24'}